China Dasheng Biotechnology Performance

CDBTDelisted Stock  USD 0.04  0.00  0.00%   
The firm shows a Beta (market volatility) of 7.7, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, China Dasheng will likely underperform. China Dasheng Biotec right now shows a risk of 0.0%. Please confirm China Dasheng Biotec total risk alpha, as well as the relationship between the potential upside and kurtosis , to decide if China Dasheng Biotec will be following its price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days China Dasheng Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, China Dasheng is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Price Earnings Ratio1.25
Total Cashflows From Investing Activities-3.9 M
  

China Dasheng Relative Risk vs. Return Landscape

If you would invest  4.24  in China Dasheng Biotechnology on November 16, 2025 and sell it today you would earn a total of  0.00  from holding China Dasheng Biotechnology or generate 0.0% return on investment over 90 days. China Dasheng Biotechnology is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than China, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

China Dasheng Target Price Odds to finish over Current Price

The tendency of China Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.04 90 days 0.04 
about 66.71
Based on a normal probability distribution, the odds of China Dasheng to move above the current price in 90 days from now is about 66.71 (This China Dasheng Biotechnology probability density function shows the probability of China Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 7.7 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, China Dasheng will likely underperform. In addition to that China Dasheng Biotechnology has an alpha of 7.2256, implying that it can generate a 7.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   China Dasheng Price Density   
       Price  

Predictive Modules for China Dasheng

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as China Dasheng Biotec. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.040.040.05
Details
Intrinsic
Valuation
LowRealHigh
0.040.040.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as China Dasheng. Your research has to be compared to or analyzed against China Dasheng's peers to derive any actionable benefits. When done correctly, China Dasheng's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in China Dasheng Biotec.

China Dasheng Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. China Dasheng is not an exception. The market had few large corrections towards the China Dasheng's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold China Dasheng Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of China Dasheng within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
7.23
β
Beta against Dow Jones7.70
σ
Overall volatility
0.03
Ir
Information ratio 0.15

China Dasheng Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of China Dasheng for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for China Dasheng Biotec can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
China Dasheng Biotec is not yet fully synchronised with the market data
China Dasheng Biotec has some characteristics of a very speculative penny stock
China Dasheng Biotec has a very high chance of going through financial distress in the upcoming years

China Dasheng Fundamentals Growth

China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Dasheng, and China Dasheng fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.

About China Dasheng Performance

Assessing China Dasheng's fundamental ratios provides investors with valuable insights into China Dasheng's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the China Dasheng is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the Peoples Republic of China. China Dasheng Biotechnology Company is based in Lanzhou, China. China Dasheng is traded on OTC Exchange in the United States.

Things to note about China Dasheng Biotec performance evaluation

Checking the ongoing alerts about China Dasheng for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Dasheng Biotec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
China Dasheng Biotec is not yet fully synchronised with the market data
China Dasheng Biotec has some characteristics of a very speculative penny stock
China Dasheng Biotec has a very high chance of going through financial distress in the upcoming years
Evaluating China Dasheng's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate China Dasheng's pink sheet performance include:
  • Analyzing China Dasheng's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Dasheng's stock is overvalued or undervalued compared to its peers.
  • Examining China Dasheng's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating China Dasheng's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Dasheng's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of China Dasheng's pink sheet. These opinions can provide insight into China Dasheng's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating China Dasheng's pink sheet performance is not an exact science, and many factors can impact China Dasheng's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in China Pink Sheet

If you are still planning to invest in China Dasheng Biotec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Dasheng's history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Content Syndication
Quickly integrate customizable finance content to your own investment portal